表 5.
178例免疫治疗NSCLC患者PFS单因素与多因素Cox回归分析
Univariate and multivariate Cox regression analysis of PFS in 178 treated with immunotherapy NSCLC patients
| Characteristics | Univariate analysis | Multivariate analysis | |||
| HR (95%CI) | P | HR (95%CI) | P | ||
| Age (< 65 yr vs ≥65 yr) | 1.017 (0.734-1.410) | 0.918 | |||
| Gender (Female vs Male) | 1.310 (0.885-1.940) | 0.177 | |||
| ECOG PS (0-1 vs 2) | 1.907 (1.270-2.865) | 0.002 | 1.275 (0.827-1.966) | 0.272 | |
| Smoking (Yes vs No) | 1.103 (0.804-1.514) | 0.543 | |||
| Histology (Squamous vs Non-squamous) | 1.030 (0.751-1.411) | 0.855 | |||
| TNM stage (III vs IV) | 1.330 (0.962-1.839) | 0.085 | |||
| Lines of treatment (1 vs ≥2) | 1.126 (0.803-1.579) | 0.493 | |||
| Option of treatment (Monotherapy vs Combination therapy) | 0.762 (0.496-1.170) | 0.214 | |||
| DNLR (< 0 vs ≥0) | 1.162 (0.844-1.600) | 0.357 | |||
| NLR (< 5 vs ≥5) | 2.318 (1.627-3.303) | < 0.001 | 1.440 (0.943-2.198) | 0.091 | |
| dNLR (≤3 vs > 3) | 1.862 (1.352-2.565) | < 0.001 | 1.546 (1.068-2.238) | 0.021 | |
| LDH (≤245 IU/L vs > 245 IU/L) | 2.399 (1.724-3.339) | < 0.001 | 2.065 (1.444-2.954) | < 0.001 | |